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E-mail address: m.m.veehof@utwente.nl (M.M. VeAcceptance-based interventions such as mindfulness-based stress reduction program and acceptance and
commitment therapy are alternative therapies for cognitive behavioral therapy for treating chronic pain
patients. To assess the effects of acceptance-based interventions on patients with chronic pain, we con-
ducted a systematic review and meta-analysis of controlled and noncontrolled studies reporting effects
on mental and physical health of pain patients. All studies were rated for quality. Primary outcome mea-
sures were pain intensity and depression. Secondary outcomes were anxiety, physical wellbeing, and
quality of life. Twenty-two studies (9 randomized controlled studies, 5 clinical controlled studies [with-
out randomization] and 8 noncontrolled studies) were included, totaling 1235 patients with chronic pain.
An effect size on pain of 0.37 was found for the controlled studies. The effect on depression was 0.32. The
quality of the studies was not found to moderate the effects of acceptance-based interventions. The
results suggest that at present mindfulness-based stress reduction program and acceptance and commit-
ment therapy are not superior to cognitive behavioral therapy but can be good alternatives. More high-
quality studies are needed. It is recommended to focus on therapies that integrate mindfulness and
behavioral therapy.
 2010 International Association for the Study of Pain. Published by Elsevier B.V.
Open access under the Elsevier OA license.1. Introduction
Chronic pain is a major health problem and has high comorbid-
ity, with depression (35%) and other psychological problems [45].
The cognitive-behavioral perspective introduced in 1983 [68]
emphasized the role of attributions, efﬁcacy expectations, personal
control, and problem solving. Cognitive behavioral therapy (CBT)
became the standard treatment for chronic pain patients who have
to deal with psychological distress and disabilities. CBT incorpo-
rates both cognitive (eg, cognitive restructuring) and behavioral
techniques (operant or respondent learning) to alter behavior.
Although there is sound evidence that CBT-based treatments are
effective with many disorders, only moderate effect sizes were re-
ported for patients with chronic pain [20,47]. Moreover, a propor-
tion of patients appears not to beneﬁt from CBT [66,69]. Therefore,
clinicians and researchers have been looking at alternatives.
In recent years there has been growing interest in acceptance-
based therapies in which the focus is not so much on controllingtudy of Pain. Published by Elsevie
ente, Department of Psychol-
oom 402, Postbus 217, 7500
; fax: +31 53 489 2388.
ehof).or ﬁghting pain, but on acceptance of pain. One of these programs
is the mindfulness-based stress reduction program (MBSR) [33].
Kabat-Zinn [33] deﬁned mindfulness as intentional and nonjudg-
mental present moment awareness. Exercises in MBSR include dif-
ferent types of formal meditation practice, yoga, and exercising
mindfulness in everyday life. Mindfulness may result in a state of
consciousness that has been described as reperceiving [61] or dec-
entering [56]. It is characterized by the ability to ‘‘disidentify from
the contents of consciousness (ie, one’s thoughts) and view his or
her moment-by-moment experience with greater clarity and
objectivity’’ [61]. Mindfulness has also been integrated with cogni-
tive therapy, called mindfulness-based cognitive therapy (MBCT)
[59], and was primarily designed to prevent depressive relapse.
Another acceptance-based intervention is acceptance and com-
mitment therapy (ACT) [26]. ACT targets ineffective control strate-
gies and experiential avoidance. People learn to stay in contact
with unpleasant emotions, sensations, and thoughts. Negative
thoughts associated with pain are used as targets for exposure
rather than attempting to change their irrational content [15].
Developing mindfulness is one of the strategies in ACT, but it is
claimed that meditation is not needed to become mindful. ACT fur-
ther focuses on value clariﬁcation and the client’s ability to commit
to these values in daily life.r B.V. Open access under the Elsevier OA license.
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the effects of acceptance-based interventions on patients with
chronic pain and to assess possible moderating factors. To our
knowledge, no such speciﬁc meta-analysis has been conducted.
Teixeira [64] reviewed the effects of meditation on pain and found
that meditation programs may help ease the burden of chronic
pain in the short and long term. However, she did not conduct a
meta-analysis nor assess the quality of the included studies. Baer
[3] conducted a meta-analysis on the effects of MBSR and found
signiﬁcant improvements on pain (0.31) and depression (0.86).
However, only 4 of her studies examined chronic pain, and she
did not include either ACT or an assessment of the quality of the
studies. Given the limited number of randomized controlled trials
(RCTs) in this ﬁeld and the explorative character of our meta-anal-
ysis, both controlled and noncontrolled studies were included.2. Methods
2.1. Search strategy
A systematic search was performed in 4 electronic databases:
PubMed (1966 to January 2009), Embase (to January 2009), Psy-
cInfo (1960 to January 2009), and the Cochrane Central Register
of Controlled Trials (1800 to January 2009). The databases were
searched for English language studies using the following terms:
‘‘mindfulness’’ or ‘‘vipassana’’ or ‘‘meditation’’ or ‘‘mindfulness-
based stress reduction’’ or ‘‘MBSR’’ or ‘‘mindfulness-based cogni-
tive therapy’’ or ‘‘MBCT’’ or ‘‘acceptance-based’’ or ‘‘acceptance
based’’ or ‘‘acceptance and commitment’’, in combination with
‘‘chronic pain’’ or speciﬁc chronic pain conditions including ‘‘ﬁbro-
myalgia’’ or ‘‘chronic fatigue syndrome’’ or ‘‘chronic low back pain’’
or ‘‘whiplash associated disorder’’ or ‘‘WAD’’ or ‘‘repetitive strain
injury’’ or ‘‘RSI’’ or ‘‘dystrophy’’. Furthermore, the reference lists
of included studies were examined for additional potentially eligi-
ble studies.
2.2. Selection of studies
Two reviewers (M.O. and M.V.) independently selected poten-
tially eligible studies on the basis of title and abstract. The inter-
rater reliability was satisfactory (Kappa = 0.80) [9], and most of
the inconsistencies in the assessments were due to conservative
scoring. Disagreements were resolved by consensus. Studies were
included if they reported on the effectiveness of a standardized
acceptance (ACT) or mindfulness (MBSR/MBCT)-based treatment
program in patients with chronic pain or chronic pain-related con-
ditions. Both controlled and noncontrolled studies were included
to estimate within-groups changes, as well as published and
unpublished (eg, dissertations) studies. Studies were excluded if
(1) the intervention consisted of a single treatment session, (2)
no abstract was available, or (3) insufﬁcient data were reported
to calculate standardized mean differences. We requested the
full-text articles. The deﬁnite selection was then made by 2
reviewers (M.O. and M.V.). The interrater reliability was very good,
with a Kappa value of 0.93 [9].
2.3. Data extraction
Data extraction and study quality assessment were performed
by 1 reviewer (M.O.) and checked by a second reviewer (M.V.)
using a standardized data abstraction form created for the study.
Disagreements were resolved, if possible, by consensus and other-
wise by consultations with a third reviewer (E.B.). Data were ex-
tracted on design (randomized controlled trial; controlled clinical
trial [CCT], without randomization; other design [OD], noncon-trolled study); country; characteristics of participants; interven-
tion type; control group; and attrition rate. In agreement with
the Clinical Importance of Treatment Outcomes in Chronic Pain
Clinical Trials (IMMPACT) recommendations [19,67], primary out-
comes of our review were pain intensity and depressive symptom-
atology. We also recorded outcome data on anxiety, quality of life,
and physical wellbeing.
2.4. Quality assessment
Methodological quality of included studies was assessed using
an 8-point scale, based on criteria by the Cochrane Collaboration
[28] and the validated Jadad scale [31] tailored for the included
studies (Table 1). The quality of a study was assessed as high when
7 or more criteria were met, medium when 4, 5, or 6 criteria were
met, and low when 3 or fewer criteria were met.
2.5. Data analysis
For this meta-analysis, Hedges’ g effect sizes were calculated
using Microsoft Excel with the following formula: g = M1 M2/
Spooled, where S =
p
[
P
(X M)2/N  1], and Spooled =
p
Mswithin.
We compared posttest scores from the control group and exper-
imental group to calculate this effect size. If no means and stan-
dard deviations were reported, other test statistics (P, t,
conﬁdence intervals) were converted into Hedges’ g [27]. We also
included noncontrolled studies, thus calculating Hedges’ g based
on pretest and posttest scores from the intervention group for
all studies. As recommended by Dunlap et al. [18], noncontrolled
studies were excluded if they did not report the means and stan-
dard deviations or the correlations between pretest and posttest
scores. Using other test statistics to calculate effect sizes in stud-
ies comparing pretest and posttest scores would give biased or
overestimated effect sizes given the correlation between the 2
scores [18]. Please note that we calculated 2 estimates for con-
trolled studies: 1 compared posttest scores between control and
experimental groups, the other compared pretest and posttest re-
sults from the experimental group. Cohen [10] has described ef-
fect sizes of 0.2, 0.5, and 0.8 as small, medium, and large,
respectively.
We used RevMan software version 5.0.18 (Copenhagen: The
Nordic Cochrane Centre, The Cochrane Collaboration, 2008) for
calculating pooled standardized mean differences (SMDs), to test
heterogeneity, and to perform subgroup analyses. Precalculated
effect sizes were manually entered using the generic inverse var-
iance outcome type. Pooled SMDs for the controlled studies
(RCTs and CCTs) were calculated using the ﬁxed-effects model
because we observed minimal clinical and methodological diver-
sity between the controlled studies. By using the ﬁxed-effects
model, it is assumed that the observed differences among study
results are solely due to the play of chance [16]. Pooled SMDs for
the noncontrolled studies (OD) were calculated using the ran-
dom-effects model, also known as the DerSimonian and Laird
model [17]. Because there is a major methodological diversity
between controlled and noncontrolled studies (eg, risk of bias
and study design), we considered studies to be heterogeneous.
When using the random-effects model, an average intervention
effect is calculated instead of an estimate of the intervention
effect.
The v2 test was used to measure signiﬁcant statistical heteroge-
neity. Statistical heterogeneity is an indicator of clinical and meth-
odological heterogeneity. The I2 statistic was calculated for
indication of the heterogeneity in percentages [29,16]. A value of
0% indicates no observed heterogeneity, and larger shows increas-
ing heterogeneity: 0 to 40% is considered as low heterogeneity, 30%
to 60% may represent moderate heterogeneity, 50% to 90% may
Table 1
Criteria methodological quality.
Criteria Scoring
1. Allocation to conditions was based on randomization according to the text 1/0
2. The randomization scheme was described and appropriate, eg, using a computer, random number table 1/0
3. A dropout analysis was conducted, or there were no dropouts 1
Reasons of attrition were reported, but no analysis was conducted 0
4. Intention to treat analysis was performed, or there were no dropouts 1/0
5. At least 1 of the trainers was experienced or trained in teaching mindfulness or ACT 1
Speciﬁc experience or training was not reported 0
6. Patient’s pain was diagnosed by a physician or rheumatologist, or patients were referred from a pain clinic where diagnosis is prior to admission 1
Recruitment through media, or diagnosis based on a scale and self-report, or diagnosis not mentioned 0
7. The study had a minimal level of statistical power to ﬁnd signiﬁcant effects of the treatment, and included 50 or more persons in the comparison between
treatment and control group (this allows the study to ﬁnd standardized effect sizes of 0.80 and larger, assuming a statistical power of 0.80 and alpha of
0.05)
1
Sample smaller than 50, or the total the sample was bigger than 50, but the results were only reported divided by different studies 0
8. Treatment integrity was checked during the study by supervision of the therapists during treatment, or by recording the treatment sessions, or by
systematic screening of protocol adherence by a standardized measurement instrument
1
Treatment integrity was not checked, or integrity was supervised by one of the therapists, or they tried to keep the intervention sound by intensive
consultation
0
ACT, acceptance and commitment therapy.
M.M. Veehof et al. / PAIN

152 (2011) 533–542 535represent substantial heterogeneity, and 75% to 100% is consider-
able heterogeneity. When using the random-effects model, the s2
statistic was calculated, which is an estimate of the between-study
variance.
Subgroup analyses were performed by testing pooled SMDs for
signiﬁcant differences in pain and depression between subgroups.
Analyses were only performed for the controlled studies, and by
the following subdivision. (1) Quality score divided by low, med-
ium, and high quality as mentioned earlier. (2) Subgroups for con-
trol group; included studies used waitlist controls, education/
support groups, or treatment as usual. One study [24] included
waitlist and no interest controls, but data were not presented sep-
arately. These data were scored as waitlist controls. One study [73]
placed participants on a waiting list, but offered them treatment as
usual as well, and were scored in this study as waitlist controls. (3)
Intervention type; ACT based or MBSR based. (4) Type of pain in 4
subgroups: mixed chronic pain populations, ﬁbromyalgia com-
bined with chronic fatigue syndrome, rheumatoid arthritis, and
speciﬁc-site pain populations (eg, chronic low back pain, chronic
headache). (5) Attrition rate higher or lower than 25%.
To assess for publication bias, we performed a funnel plot for
pain and depression [16] for the controlled studies by plotting
the pooled SMD against study size. When publication bias is ab-
sent, the studies can be expected to be distributed symmetrically
around the pooled effect size. Bias can be expected when the plot
shows a higher concentration of studies on one side of the pooled
SMD than on the other.
3. Results
Initially, 1121 titles were retrieved from the databases (PubMed
894, PsycInfo 89, Cochrane 32, Embase 106). After review of title
and abstract and removal of duplicates, 40 studies were identiﬁed
as being potentially eligible for inclusion in the study. Full-text ver-
sions of these articles were obtained and independently assessed
by 2 reviewers (M.O. and M.V.). Twenty-one of the 40 articles were
excluded for the following reasons: no acceptance-based
intervention [8,12,21,38,40,44,65], insufﬁcient data [32,34–36,
46,51,53,54,72], sample contained other than pain patients
[1,7,11], same sample used in 2 publications [58], and inconsis-
tencies in the intervention protocol [74]. Therefore, 19 studies
were included in this systematic review, 14 controlled [2,6,15,
22,24,25,48,49,52,57,60,62,73,75], and 5 noncontrolled [41,43,50,
70,71]. Nine of the controlled studies were RCTs [2,6,15,48,49,
52,60,73,75], the others were CCTs. One controlled study also
included 2 noncontrolled substudies, which we also included[62]. One noncontrolled study reported on 2 substudies, which
we included [70].
3.1. Characteristics of included studies
Characteristics of the selected studies are presented in Table 2.
The 22 (sub-)studies included in the analysis evaluated 1235 sub-
jects. In general, the participants were adults with a mean age be-
tween 40 and 60 years. In all studies, except 1 [70], the majority of
the participants was female. In 6 studies the attrition rate was
higher than 25% (range 25.3% to 49.0%). Fifteen studies measured
pain, 17 depression, 13 anxiety, 13 physical wellbeing, and 5 qual-
ity of life. All instruments had good psychometric properties. Study
size ranged from a small pilot study of 6 subjects [70] to a large-
scale study involving 171 subjects [71]. Median study size was
46 subjects (interquartile range 16.8 to 90.3). Fifteen studies used
a MBSR(-based) program, and 7 studies an ACT(-based) program.
Most MBSR-based studies held 8 weekly sessions in a range from
1.5 hours to 2.5 hours (median 2 hours). Half of the ACT-based
studies treated their patients full time for 3 or 4 weeks. The other
studies held 4 to 10 weekly sessions in a range from 1 hours to
1.5 hours. In general, group sizes ranged from 6 persons to 25.
Some studies used smaller groups [50,71], or even individual ses-
sions [15,73]. Nine studies included patients with some sort of
chronic pain, 4 with ﬁbromyalgia, 2 with rheumatoid arthritis, 4
with chronic fatigue syndrome, and 3 studies included patients
with speciﬁc site pain (eg, chronic low back pain). With respect
to the controlled studies, 7 used a waitlist control, 3 used treat-
ment as usual, and 4 used an education/support group as compar-
ison group. Two studies scored high on the quality criteria, 8
scored medium, and 12 scored low. None of the studies met all
quality criteria.
3.2. Publication bias
Some indication for publication bias was found for the outcome
measure depression. The funnel plot for depression is presented in
Fig. 1, and shows asymmetrically distributed studies in the bottom
of the ﬁgure. In the presence of bias, it can be expected that the
bottom of the plot, which displays smaller studies, shows a higher
concentration of studies on one side of the pooled SMD than on
the other. This is due to the fact that smaller studies are more
likely to be published if they have larger-than-average effects
[5]. The funnel plot for pain was symmetrically distributed around
the pooled SMD, which is an indication for the absence of publica-
tion bias.
Table 2
Characteristics of included studies.
Author Study
design
Quality
score
Pain Mean age
(SD or range)
Male,
%
Intervention Group
size
Sessions (number),
duration
Control
group
n Attrition
rate, %
Outcome
measures
McCracken (2007) OD 3 Highly disabled chronic pain
patients
47.6 (11.6) 35.8 ACT 3 weeks full time,
80 h
– 53 0 Pain: NRS
Depression: BDI
Anxiety: PASS
Physical: SIP
McCracken (2005) OD 2 Complex chronic pain 44.4 (10.7) 35.8 ACT 3 or 4 weeks full
time
– 108 23.9 Pain: NRS
Depression: BDI
Anxiety: PASS
Physical: SIP
Pauzano-Slamm
(2005)
OD 3 Chronic fatigue syndrome 52.4 (14.2) 23.6 MBSR 4–5 8, 1.5 h – 16 17.7 Depression: BDI
Anxiety: BSI-18
Surawy (2005)
Study 2
OD 2 Chronic fatigue syndrome (18–65) 25 MBSR 12 8 – 10 18.2 Depression: HADS
Anxiety: HADS
Physical: SF-36
Surawy (2005)
Study 3
OD 2 Chronic fatigue syndrome (18–65) 36 MBSR 11 8 – 9 18.2 Depression: HADS
Anxiety: HADS
Physical: SF-36
Vowles (2009)
Study 1
OD 1 Chronic pain 49.5 (6.9) 36.4 ACT 6 8, 1.5 h – 11 31.3 Pain: MPQ
Depression CES-D
Anxiety: PASS
Physical: PDI
Vowles (2009)
Study 2
OD 1 Chronic pain 50.4 (17.8) 82 ACT 2–3 4, 1.5 h – I: 6 Pain: MPQ
Depression: CES-D
Anxiety: PASS
Physical: PDI
Vowles (2008) OD 3 Chronic pain 47.3 (11.4) 35.8 ACT 3 or 4 weeks full
time
– 171 8.6 Pain: NRS
Depression:
BCMDI
Anxiety: PASS
Physical: SIP
Gardner-Nix (2008) CCT 1 Chronic pain I: 51
C: 52
I: 20
C: 25
MBSR 10–20 10, 2 h Waitlist I: 99
C: 57
I: 49
C: 10
Pain: NRS
Physical: SF-36
Goldenberg (1994) CCT 3 Fibromyalgia I: 46 (9.9)
C: 47.2 (11.8)
I: 10
C: 3
MBSR 7–12 10, 2 h Waitlist (n = 18)
No interest (n = 24)
I: 79
C: 42
I: 9.2 Pain: VAS
QoL: FIQ
Grossman (2007) CCT 3 Fibromyalgia T: 52 (8)
I: 54.4 (8.3)
C: 48.8 (9.1)
0 MBSR 10–15 8, 2.5 h Education/
support
I: 39
C: 13
T: 10.3
I: 9.3
C: 13.3
Pain: VAS
Depression: HADS
Anxiety: HADS
QoL: QoL
Sagula (2004) CCT Chronic pain 23.9 MBSR 7–10 8, 1.5 h TAU I: 39
C: 18
T: 19.7
I: 20.4
C:18.2
Depression: BDI
Anxiety: STAI
Surawy (2005)
Study 1
CCT 2 Chronic fatigue syndrome (18–65) 44.4 MBSR 9 8 Waitlist I: 9
C: 8
T: 6 Depression: HADS
Anxiety: HADS
Physical: SF-36
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Astin (2003) RCT 5 Fibromyalgia T: 47.7 (10.6) T: 0.8
I: 1.6
C: 0
MBSR + Qigong 10–20 8, 2.5 h Education/support I: 32
C: 33
T: 39 Pain: SF-36
Depression: BDI
QoL: FIQ
Bruckstein (1999) RCT 7 Chronic pain T: 56.4 (13.7) T: 26.6
I: 22.7
C: 38.9
MBSR 8, 1.5 h Education/support I: 15
C: 7
T: 30.4
I: 29.2
C: 31.8
Pain: VAS
Depression: BDI
Anxiety: SCL-90
Physical: SIP
Dahl (2004) RCT 4 Chronic pain T: 40 (13.2)
I: 36.7 (12.5)
C: 44.4 (13.6)
10.5 ACT Individual 4, 1 h TAU I: 11
C: 8
0 Pain: NRS
QoL: LSQ
Morone (2008) RCT 5 Chronic low back pain T: 74.9
(65–84)
43 MBSR 8, 1.5 h Waitlist I: 19
C: 18
T: 19
I: 32
C: 6
Pain: MPQ-SF
Physical: SF-36
QoL: SF-36
Nash-Mc Feron
(2006)
RCT 5 Chronic headache I: 50 (14.6)
C: 51 (12.2)
I: 0
C: 35
MBSR 20 8, 1.5 h TAU I: 20
C: 20
I: 5
C:10
Pain: SF-36
Physical: SF-36
Pradhan (2007) RCT 6 Rheumatoid arthritis I: 56 (9)
C: 53 (11)
I: 16
C: 9
MBSR Cohort
I: 18
Cohort
II: 13
8, 2.5 h Waitlist I: 32
C: 32
Depression: SCL-
90
Sephton (2007) RCT 6 Fibromyalgia T: 48.2 (10.6)
I: 48.4 (8.9)
C: 47.6 (11.5)
0 MBSR 25 8, 2.5 h Waitlist I: 51
C: 39
25.3 Depression: BDI
Wicksell (2008) RCT 5 Whiplash-associated disorders I: 48.2 (7.8)
C: 55.1 (11.2)
38.5 ACT Individual 10, 1 h Waitlist + TAU I: 11
C: 9
T: 4.8
I: 0
C: 10
Pain: VAS
Depression: HADS
Anxiety: HADS
Physical: PDI
QoL: SWLS
Zautra (2008) RCT 7 Rheumatoid arthritis I: 57.3 (15.3)
C: 52.4 (13.0)
31.9 MBSR 6–10 8 Education/support I: 47
C: 44
T: 3.5–
4.3
Pain: NRS
Depression: own
scale
ACT, acceptance and commitment therapy; CBT, cognitive behavioural therapy; MBSR, mindfulness-based stress reduction; C, control group; I, intervention group; T, total group; CCT, controlled clinical trial; RCT, randomized
controlled trial; OD, other design; SD, standard deviation; BCMDI, British Columbia Major Depression Inventory; BDI, Beck Depression Inventory; BSI-18, Brief Symptom Inventory 18; CES-D, Center for Epidemiologic Studies
Depression Scale; FIQ, Fibromyalgia Impact Questionnaire; HADS, Hospital Anxiety and Depression Scale; LSQ, Life Satisfaction Questionnaire; MPQ, McGill Pain Questionnaire; NRS, numerical rating scale; PASS, Pain Anxiety
Symptoms Scale; PDI, Pain Disability Index; POMS, Proﬁle of Mood States; QoL (outcome measure), Quality of Life Proﬁle for the Chronically Ill; SCL-90, 90-item symptom checklist; SF-36, 36-Item Short-Form Health Survey; SIP,
Sickness Impact Proﬁle; STAI, State-Trait Anxiety Inventory; SWLS, Satisfaction With Life Scale; VAS, Visual Analogue Scale.
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Fig. 1. Funnel plot for depression.
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and noncontrolled studies
Pooled SMDs and the results of the tests for heterogeneity and
overall effect are presented in Table 3. Moderate effect sizes were
found for pain (SMD = 0.47; 95% CI: 0.28 to 0.66) and depression
(SMD = 0.64; 95% CI: 0.43 to 0.85) when pretest and posttest scores
of all studies were analyzed. These effects were signiﬁcant
(P < .01). Moderate and signiﬁcant effects were also found for anx-
iety, physical wellbeing, and quality of life, with pooled SMDs rang-
ing from 0.48 to 0.69.
3.4. Effects for the controlled studies
When the CCTs were analyzed, moderate and signiﬁcant ef-
fects were found for pain (SMD = 0.48; 95% CI: 0.25 to 0.71)
and depression (SMD = 0.50; 95% CI: 0.12 to 0.89). Analyses of
the RCTs showed small effects on pain and depression with
pooled SMDs of respectively 0.25 (95% CI: 0.01 to 0.49) andTable 3
Effects.
Outcome measures n Studies Pooled SMD [
Effects for pre- and posttest scores (all studies included)
Pain 14 [2,6,15,22,25,41,43,49,48,70,71,73,75] 0.43 [0.22–0.
Depression 17 [2,6,25,41,43,50,52,57,62,60,70,71,73,75] 0.69 [0.47–0.
Anxiety 13 [6,25,41,43,50,57,62,70,71,73] 0.69 [0.51–0.
Physical wellbeing 13 [6,22,41,43,48,62,70,71,73] 0.48 [0.27–0.
Quality of life 5 [2,15,25,48,73] 0.63 [0.28–0.
Effects for CCTs
Pain 3 [22,24,25] 0.48 [0.25–0.
Depression 3 [25,57,62] 0.50 [0.12–0.
Anxiety 3 [25,57,62] 0.34 [0.04–
Physical wellbeing 2 [22,62] 0.29 [0.02–
Quality of life 2 [24,25] 0.57 [0.22–0.
Effects for RCTs
Pain 7 [2,6,15,48,49,73,75] 0.25 [0.01–0.
Depression 6 [2,6,52,60,73,75] 0.26 [0.05–0.
Anxiety 2 [6,73] 0.55 [0.09–
Physical wellbeing 4 [6,48,49,73] 0.43 [0.04–0.
Quality of life 4 [2,15,48,73] 0.25 [0.10–
Effects for all controlled studies (CCTs and RCTs)
Pain 10 [2,6,15,22,24,25,48,49,73,75] 0.37 [0.20–0.
Depression 9 [2,6,25,52,57,60,62,73,75] 0.32 [0.13–0.
Anxiety 5 [6,25,57,62,73] 0.40 [0.07–0.
Physical wellbeing 6 [6,22,48,49,62,73] 0.35 [0.10–0.
Quality of life 6 [2,15,24,25,48,73] 0.41 [0.16–0.
RCT, randomized controlled trial; CCT, controlled clinical trial; SMD, standardized mean0.26 (95% CI: 0.05 to 0.47). Effects were still signiﬁcant. Both
the CCTs and the RCTs showed small to moderate effects on anx-
iety, physical wellbeing, and quality of life. Only the effects for
quality of life (CCTs; SMD = 0.57) and physical wellbeing (RCTs;
SMD = 0.43) were signiﬁcant. Please note that the number of
studies was small when the CCTs and the RCTs were analyzed
separately.
Pooling the results of all controlled studies (CCTs and RCTs)
gave small but signiﬁcant effects, with a pooled SMD of 0.37
(95% CI: 0.20 to 0.53) for pain, 0.32 (95% CI: 0.13 to 0.50) for
depression, 0.40 for anxiety (95% CI: 0.07 to 0.73), 0.35 for physical
wellbeing (95% CI: 0.10 to 0.59), and 0.41 for quality of life (95% CI:
0.16 to 0.65). When studies scored as low quality were excluded,
the SMD for pain dropped to 0.25 (95% CI: 0.01 to 0.49) and for
depression dropped to 0.30 (95% CI: 0.10 to 0.49).
3.5. Subgroup analyses
Subgroup analyses are presented in Table 4. There were no sig-
niﬁcant differences between subgroups in the effects on pain or
depression (P > .05) between the different subgroups, except for
publication status. Unpublished studies reported higher effects
(SMD = 0.90) on pain than published studies (SMD = 0.32), but note
that only 2 unpublished studies were included in this subgroup
analysis.4. Discussion
4.1. Main ﬁndings
This was an explorative meta-analysis of studies on the effects
of acceptance-based therapies on mental and physical health in pa-
tients with chronic pain. When all studies focusing on change score
before and after treatment were included in the meta-analysis, we
found medium effect sizes for pain intensity, depression, anxiety,
physical wellbeing, and quality of life. This ﬁnding shows that in
general, patients with chronic pain respond reasonably well to
acceptance-based therapies.95% CI] Heterogeneity Test for overall effect
64] s2 = 0.08; v2 = 34.72, df = 13 (P < .01); I2 = 63% Z = 4.06 (P < .01)
92] s2 = 0.12; v2 = 49.04, df = 16 (P < .01); I2 = 67% Z = 6.18 (P < .01)
88] s2 = 0.03; v2 = 18.24, df = 12 (P = .11); I2 = 34% Z = 7.39 (P < .01)
68] s2 = 0.06; v2 = 24.66, df = 12 (P = .02); I2 = 51% Z = 4.48 (P < .01)
98] s2 = 0.05; v2 = 5.78, df = 4 (P = .22); I2 = 31% Z = 3.58 (P < .01)
71] v2 = 0.12, df = 2 (P = .94); I2 = 0% Z = 4.07 (P < .01)
89] v2 = 0.11, df = 2 (P = .94); I2 = 0% Z = 2.56 (P = .01)
0.73] v2 = 0.88, df = 2 (P = .64); I2 = 0% Z = 1.75 (P = .08)
0.61] v2 = 0.10, df = 1 (P = .76); I2 = 0% Z = 1.82 (P = .07)
91] v2 = 0.05, df = 1 (P = .82); I2 = 0% Z = 3.19 (P < .01)
49] v2 = 8.46, df = 6 (P = .21); I2 = 29% Z = 2.06 (P = .04)
47] v2 = 6.46, df = 5 (P = .26); I2 = 23% Z = 2.39 (P = .02)
1.18] v2 = 0.05, df = 1 (P = .82); I2 = 0% Z = 1.68 (P = .09)
82] v2 = 2.06, df = 3 (P = .56); I2 = 0% Z = 2.16 (P = .03)
0.59] v2 = 3.02, df = 3 (P = .39); I2 = 1% Z = 1.41 (P = .16)
53] v2 = 10.41, df = 9 (P = .32); I2 = 14% Z = 4.36 (P < .01)
50] v2 = 7.75, df = 8 (P = .46); I2 = 0% Z = 3.32 (P = .01)
73] v2 = 1.21, df = 4 (P = .88); I2 = 0% Z = 2.36 (P = .02)
59] v2 = 2.44, df = 5 (P = .79); I2 = 0% Z = 2.78 (P < .01)
65] v2 = 4.68, df = 5 (P = .46); I2 = 0% Z = 3.25 (P < .01)
difference; 95% CI, 95% conﬁdence interval; df, degrees of freedom.
Table 4
Subgroup analyses of all controlled studies on pain and depression.
Outcome measure Criteria Subgroup n SMD [95% CI] Test for subgroup differences
Pain Quality Low quality [22,24,25] 3 0.48 [0.25–0.71] v2 = 1.85, df = 2 (P = .40)
Medium quality [2,15,48,49,73] 5 0.24 [0.07–0.54]
High quality [6,75] 2 0.27 [0.11–0.65]
Intervention ACT [15,73] 2 0.29 [0.35–0.94] v2 = 0.06, df = 1 (P = .81)
MBSR [2,6,24,25,22,48,49,75] 8 0.37 [0.20–0.54]
Control group Education/support [2,6,25,75] 4 0.20 [0.07–0.47] v2 = 2.32, df = 2 (P = .31)
TAU [15,49] 2 0.51 [0.03–1.05]
Waitlist [22,24,48,73] 4 0.46 [0.23–0.69]
Pain type Chronic pain [6,15,22] 3 0.49 [0.19–0.79] v2 = 2.76, df = 3 (P = .43)
Fibromyalgia [2,24,25] 3 0.34 [0.07–0.61]
Special site pain [49,48,73] 3 0.49 [0.06–0.92]
Rheumatoid arthritis [75] 1 0.09 [0.32–0.50]
Attrition rate <25% [15,24,25,49,73,75] 6 0.38 [0.16–0.61] v2 = 0.04, df = 1 (P = .83)
>25% [2,6,22,48] 4 0.35 [0.10–0.60]
Publish status Unpublished [6,49] 2 0.90 [0.35–1.45] v2 = 3.89, df = 1 (P = .05)
Published [2,15,22,24,25,48,73,75] 8 0.32 [0.14–0.49]
Depression Quality Low quality [62,25] 2 0.45 [0.07–0.98] v2 = 0.31, df = 2 (P = .86)
Medium quality [2,52,57,60,73] 5 0.30 [0.06–0.53]
High quality [6,75] 2 0.29 [0.08–0.67]
Intervention MBSR [2,6,25,52,57,60,62,75] 8 0.28 [0.09–0.47] v2 = 2.71, df = 1 (P = .10)
ACT [73] 1 1.09 [0.15–2.03]
Control group Education/support [62,52,60,73] 4 0.29 [0.02–0.56] v2 = 0.79, df = 2 (P = .67)
Waitlist [6,2,25,75] 4 0.29 [0.00–0.58]
TAU [57] 1 0.56 [0.01–1.13]
Pain type Chronic pain [6,57] 2 0.63 [0.15–1.11] v2 = 6.17, df = 3 (P = .10)
Fibromyalgia + CFS [2,25,62,60] 4 0.32 [0.05–0.59]
Rheumatoid arthritis [52,75] 2 0.09 [0.23–0.41]
Special site pain [73] 1 1.09 [0.15–2.03]
Attrition rate <25% [25,52,57,62,73,75] 6 0.31 [0.07–0.55] v2 = 0.01, df = 1 (P = .94)
>25% [2,6,60] 3 0.32 [0.03–0.62]
Publish status Unpublished [6] 1 0.81 [0.11–1.73] v2 = 1.15, df = 1 (P = .28)
Published [2,25,52,57,60,62,73,75] 8 0.29 [0.10–0.48]
SMD, standardized mean difference; 95% CI, 95% conﬁdence interval; ACT, acceptance and commitment therapy; MBSR, mindfulness-based stress reduction program; TAU,
treatment as usual; CFS, chronic fatigue syndrome; df, degrees of freedom.
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152 (2011) 533–542 539On the basis of 10 controlled studies, it was found that MBSR
and ACT have a small effect (SMD = 0.37) on pain intensity. Impor-
tantly, within this sample of controlled studies no heterogeneity
was found. This is an indication of the robustness of the ﬁnding.
In other meta-analyses, comparable effects were found for CBT
[30,20,47]. Moreover, Baer [3] found a similar effect size for mind-
fulness interventions in an earlier meta-analysis. Based on the
principle of best evidence, it makes sense to include only RCTs or
to exclude the studies with low quality. In both cases, a smaller ef-
fect size (SMD = 0.25, 0.22) was found. Differences, however, were
not signiﬁcant. Although pain intensity was the most used out-
come measure in the included studies, which is in accordance with
the IMMPACT recommendations, it is important to note that reduc-
tion of pain intensity is not a primary focus of acceptance-based
therapies. Participants learn to let go of pain control strategies in
favor of acceptance of pain as a part of their daily lives. The pain
per deﬁnition being chronic, larger effect sizes may not be ex-
pected. So, it is questionable whether pain intensity is the most
appropriate outcome measure for acceptance-based interventions
in chronic pain patients. For future studies, it is recommended
not to solely rely on pain intensity as an outcome measure but also
to include other pain measures such as interference of pain with
daily life. The number of studies that assessed other pain measures
was too small to include these outcomes in this meta-analysis.
In a similar way, it was found that acceptance-based therapies
have a small effect (SMD = 0.32) on depression. No indication for
heterogeneity was found in this cluster of studies either. This effect
is comparable with the effect sizes found for CBT, whereas we
hypothesized that precisely acceptance would lead to a larger
reduction of depressive symptomatology. What could explain this
result? One possible factor could be a ﬂoor effect, as mentioned byPradhan et al. [52]. When patients with lower levels of depression
are included in studies, there is less room for improvement. Unfor-
tunately we could not study this explanation empirically because
different instruments were used and many instruments do not
have clear cutoff scores. Another explanation could be that ACT
has more similarities than differences with CBT. However, this
could only be part of the explanation because just 1 small ACT
study was included in this meta-analysis. The others were MBSR
based. A ﬁnal explanation could be that the effectiveness of MBSR
speciﬁcally on depression is limited [4]. MBSR was developed as a
general stress reduction program, mainly combining meditation
with psychoeducation. In recent years, new programs have been
developed that integrate MBSR with behavioral therapy [55,63].
There is more focus on behavioral change. Mindfulness may very
well facilitate effective mechanisms of behavioral therapy [61].
Preliminary studies show promising results [55,63]. In contrast to
MBSR, ACT is an intervention with more focus on behavioral
change. The one ACT study that was included in this meta-analysis
showed a large effect on depression.
Fewer studies reported the effects of ACT and MBSR on anxiety,
physical functioning, and quality of life. On the basis of the in-
cluded controlled studies, it can be concluded that acceptance-
based interventions have small effects on these measures.
With respect to the quality of the studies, it was found that
quality did not signiﬁcantly moderate the effects of acceptance-
based interventions. This result is somewhat surprising. In several
recent, large meta-analyses on the effects of psychotherapy and
pharmacotherapy, it has been found that lower effects were found
in higher-quality studies [13,14,23,37]. However, only 2 high-
quality studies were included in this study, so these ﬁndings have
to be interpreted with caution. Other factors (type of intervention,
540 M.M. Veehof et al. / PAIN

152 (2011) 533–542control group and pain, attrition rate) also did not signiﬁcantly
moderate the effects of acceptance-based therapy with chronic
pain patients. One exception was publication status, with unpub-
lished studies reporting higher effects on pain intensity.
For the studies on pain intensity and depression, funnel plots
were conducted to check the possibility of publication bias. A sym-
metrical funnel plot was found for pain intensity, suggesting the ab-
sence of publication bias. For depression, in the lower left side of the
funnel plot, studies were lacking. This may be an indication of pub-
lication bias, as studies with small samples that found no or small
effects may be underrepresented in the published articles [5]. The
only 2 unpublished studies that could be included in themeta-anal-
ysis, however, reported a signiﬁcantly higher effect size than the
published studies. But it could be thatmore unpublished studies ex-
ist than were represented in the databases we used in this review.
It is important to note that at present, acceptance-based inter-
ventions and CBT produce small but equivalent effects. Given the
relatively large number of high-quality studies in CBT, CBT cur-
rently remains the standard treatment. Treatment outcomes, how-
ever, could be improved if treatments are matched to patient
characteristics [66,69]. Recurrent depression might be one impor-
tant factor for referring patients to either an acceptance-based
intervention or CBT. Recently, Zautra et al. [75] have shown that
rheumatoid arthritis patients with recurrent depression beneﬁted
more from an acceptance-based intervention than from CBT, com-
pared to patients with no recurrent depression. Experiential avoid-
ance and low levels of meaning in life might be other factors. Given
their primary focus on decreasing experiential avoidance (or
improving acceptance) in combination with exploring values and
value-based living, acceptance-based interventions might be more
suitable for patients with high levels of experiential avoidance and
lower levels of meaning in life than CBT. More research is needed
to conﬁrm these ﬁndings and to ﬁnd other characteristics that
seem important in referring patients to either CBT or MBSR or
ACT, as has been recommended by several scientists [66,69].5. Study limitations
This study has several limitations. First, we found only 2 high-
quality studies and no study that met all criteria. This could be
an underestimation, because quality criteria were scored conserva-
tively. When a criterion was not reported in the article, we coded
this criterion as negative. It is quite plausible that authors chose
to omit certain study characteristics owing to lack of space in the
journal. Clearly more high-quality studies are needed to conﬁrm
the reported results with regard to effectiveness and quality as a
moderating factor. A second limitation is that insufﬁcient data
were reported to conduct a meta-analysis of the long-term effects
of acceptance-based interventions. Third, PsycInfo solely retrieves
unpublished dissertations from North America. Excluding non-
American dissertations could lead to bias. Fourth, the subgroup
analyses were based on all controlled studies. Given the small
number of RCTs, it was not possible to separate the results of the
RCTs from the CCTs, which probably would have led to lower effect
sizes. Fifth, the representativeness of the participants in some
studies was limited. Some patients (eg, rheumatoid arthritis pa-
tients) were not representative of those referred to pain clinics.
Furthermore, some studies reported a high attrition rate. Both
may limit the generalizability of the ﬁndings. Sixth, the studies
we found were not included in a previous meta-analysis [20] on
the effects of psychological therapies in chronic pain. This could
be explained by the different criteria we used. We considered
MBSR as a psychological intervention. Furthermore, we included
small studies, such as 1 ACT study [15]. Moreover, 1 of our ACT
studies [73] was just published after the search of the previousmeta-analysis was ﬁnished. A ﬁnal limitation of this study is the
small number of studies in some subgroups. For example, only 2
small studies on the effects of ACT on pain intensity were found,
and 1 study on the effects on depression. More (randomized) con-
trolled studies are thus needed to allow more solid conclusions
about most moderating factors.
6. Conclusions and implications
Despite the limitations, this meta-analysis shows that accep-
tance-based therapies have small to medium effects on physical
and mental health in chronic pain patients that are comparable
to CBT. However, given the important role acceptance andmindful-
ness play in adaptation to chronic pain [39,41,42], the develop-
ment of more effective therapies is warranted. A promising new
direction is therapies that integrate MBSR with behavioral therapy
[70]. However, few studies have been conducted with chronic pain
patients to date. ACT seems promising as well, but more studies are
needed to study its effectiveness with chronic pain patients.
All in all, more high-quality studies are needed, and future stud-
ies should bear in mind some quality criteria. We would like to
conclude with stressing the importance of reporting these quality
criteria. Without reporting relevant quality criteria, quality assess-
ments lead to unjust lower-quality scoring in reviews.Acknowledgements
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